The NHS hasn't been prioritised in the Brexit negotiations, and that means serious trouble ahead
The Independent -

How will the UK continue to secure a consistent supply of medical radioisotopes for cancer treatment once we leave the EU? Could the introduction of a separate regulatory system for medicines in the UK lead to patients facing delays of up to 24 months to access lifesaving drugs?


Related Articles